SEC Form D · Amendment · filed July 8, 2021
Allay Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Leighton D. Read · Menlo Park, CADirectorMark A. Deem · Menlo Park, CADirectorMichael A. Carusi · Menlo Park, CADirectorJosh D. Makower · Menlo Park, CADirectorAdam D. Gridley · Menlo Park, CAExec · DirectorTak D. Cheung · Menlo Park, CADirectorKarun D. Naga · Menlo Park, CADirectorZachary K. Ellis · Pittsburgh, PADirectorAdel C. Alderbas · New York, NYDirectorKathryn C. Leaf · San Francisco, CADirectorNathan A. Lutz · Uniontown, PADirectorOlin J. Utterback · New York, NYExec · DirectorMirza J. Galeano · New York, NYDirectorMichael Vinci · Manhattan Beach, CADirectorPol-Henri N. Lebrun · Luxembourg, LuxembourgDirectorRomain N. Delvert · Luxembourg, LuxembourgDirectorNigel N. Williams · Luxembourg, LuxembourgExec · DirectorJeremy Kranz · SAN FRANCISCO, CADirectorTiffany Kosch · AUSTIN, TXDirectorKarun D. Naga · Menlo Park, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗